Ontology type: schema:ScholarlyArticle Open Access: True
2020-01-06
AUTHORSKanako Kurata, Makoto Kubo, Masaya Kai, Hitomi Mori, Hitomi Kawaji, Kazuhisa Kaneshiro, Mai Yamada, Reiki Nishimura, Tomofumi Osako, Nobuyuki Arima, Masayuki Okido, Yoshinao Oda, Masafumi Nakamura
ABSTRACTBackgroundIt is important to identify biomarkers for triple-negative breast cancers (TNBCs). Recently, pembrolizumab, an immune checkpoint inhibitor (ICI) for programmed cell death 1 (PD-1), was approved as a treatment strategy for unresectable or metastatic tumor with high-frequency microsatellite instability (MSI-H) or mismatch repair deficiency, such as malignant melanoma, non-small cell lung cancer, renal cell cancer and urothelial cancer. In addition, results from clinical trials suggested that ICI was a promising treatment for TNBCs with accumulated mutations. However, the frequency of MSI in Japanese TNBCs still remains unclear. We aimed to analyze the presence of MSI-H in TNBCs as a biomarker for ICI therapy.MethodsIn this study, we retrospectively evaluated the MSI of 228 TNBCs using an innovative method, MSI Analysis System Version 1.2 (Promega), consisting of 5 microsatellite markers: BAT-26, NR-21, BAT-25, MONO-27 and NR-24 without a normal tissue control.ResultsAmong 228 tumors, 222 (97.4%) were microsatellite stable, 4 (1.7%) low-frequency MSI and 2 (0.9%) MSI-H, respectively. Two MSI-H tumors were potentially aggressive pathologically as indicated by nuclear grade 3 and high Ki-67 (> 30%), and were classified as basal-like and non-BRCA-like, but were not consistent regarding tumor-infiltrating lymphocytes, CD8 and PD-L1 expression.ConclusionsAlthough we found that MSI-H was uncommon (0.9%) in TNBCs, potential targets for ICIs exist in TNBCs. Therefore, MSI-H breast cancer patients should be picked up using not only conventional methods but also platforms for comprehensive genomic profiling. More... »
PAGES490-498
http://scigraph.springernature.com/pub.10.1007/s12282-019-01043-5
DOIhttp://dx.doi.org/10.1007/s12282-019-01043-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1123831481
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/31907878
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Microsatellite Instability",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prognosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptor, ErbB-2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Estrogen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptors, Progesterone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Rate",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Triple Negative Breast Neoplasms",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Kurata",
"givenName": "Kanako",
"id": "sg:person.012512352422.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012512352422.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Kubo",
"givenName": "Makoto",
"id": "sg:person.01333511303.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333511303.40"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Kai",
"givenName": "Masaya",
"id": "sg:person.01272322541.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272322541.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Mori",
"givenName": "Hitomi",
"id": "sg:person.010432723555.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010432723555.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Kawaji",
"givenName": "Hitomi",
"id": "sg:person.012002302436.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012002302436.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Kaneshiro",
"givenName": "Kazuhisa",
"id": "sg:person.016344762635.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016344762635.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Yamada",
"givenName": "Mai",
"id": "sg:person.015611147155.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015611147155.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Breast Center, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Breast Center, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan"
],
"type": "Organization"
},
"familyName": "Nishimura",
"givenName": "Reiki",
"id": "sg:person.013173055502.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013173055502.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Breast Center, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Breast Center, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan"
],
"type": "Organization"
},
"familyName": "Osako",
"givenName": "Tomofumi",
"id": "sg:person.01175256736.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175256736.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Pathology, Kumamoto Shinto General Hospital, 3-2-65 Oe, Chuo-ku, 862-8655, Kumamoto, Japan"
],
"type": "Organization"
},
"familyName": "Arima",
"givenName": "Nobuyuki",
"id": "sg:person.016542450374.76",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016542450374.76"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-ku, 810-8539, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.413617.6",
"name": [
"Department of Surgery, Hamanomachi Hospital, 3-3-1 Nagahama, Chuo-ku, 810-8539, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Okido",
"givenName": "Masayuki",
"id": "sg:person.0763112563.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763112563.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Oda",
"givenName": "Yoshinao",
"id": "sg:person.0730707143.99",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730707143.99"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan",
"id": "http://www.grid.ac/institutes/grid.177174.3",
"name": [
"Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, 812-8582, Fukuoka, Japan"
],
"type": "Organization"
},
"familyName": "Nakamura",
"givenName": "Masafumi",
"id": "sg:person.015151406364.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015151406364.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s10549-019-05256-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1113995874",
"https://doi.org/10.1007/s10549-019-05256-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/ncomms15180",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1085883879",
"https://doi.org/10.1038/ncomms15180"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/35021093",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033846543",
"https://doi.org/10.1038/35021093"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nm0296-169",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028904279",
"https://doi.org/10.1038/nm0296-169"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature11412",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024942368",
"https://doi.org/10.1038/nature11412"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s40425-018-0341-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1103407654",
"https://doi.org/10.1186/s40425-018-0341-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1245/s10434-016-5173-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024468668",
"https://doi.org/10.1245/s10434-016-5173-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature11252",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010619765",
"https://doi.org/10.1038/nature11252"
],
"type": "CreativeWork"
}
],
"datePublished": "2020-01-06",
"datePublishedReg": "2020-01-06",
"description": "BackgroundIt is important to identify biomarkers for triple-negative breast cancers (TNBCs). Recently, pembrolizumab, an immune checkpoint inhibitor (ICI) for programmed cell death 1 (PD-1), was approved as a treatment strategy for unresectable or metastatic tumor with high-frequency microsatellite instability (MSI-H) or mismatch repair deficiency, such as malignant melanoma, non-small cell lung cancer, renal cell cancer and urothelial cancer. In addition, results from clinical trials suggested that ICI was a promising treatment for TNBCs with accumulated mutations. However, the frequency of MSI in Japanese TNBCs still remains unclear. We aimed to analyze the presence of MSI-H in TNBCs as a biomarker for ICI therapy.MethodsIn this study, we retrospectively evaluated the MSI of 228 TNBCs using an innovative method, MSI Analysis System Version 1.2 (Promega), consisting of 5 microsatellite markers: BAT-26, NR-21, BAT-25, MONO-27 and NR-24 without a normal tissue control.ResultsAmong 228 tumors, 222 (97.4%) were microsatellite stable, 4 (1.7%) low-frequency MSI and 2 (0.9%) MSI-H, respectively. Two MSI-H tumors were potentially aggressive pathologically as indicated by nuclear grade 3 and high Ki-67 (>\u200930%), and were classified as basal-like and non-BRCA-like, but were not consistent regarding tumor-infiltrating lymphocytes, CD8 and PD-L1 expression.ConclusionsAlthough we found that MSI-H was uncommon (0.9%) in TNBCs, potential targets for ICIs exist in TNBCs. Therefore, MSI-H breast cancer patients should be picked up using not only conventional methods but also platforms for comprehensive genomic profiling.",
"genre": "article",
"id": "sg:pub.10.1007/s12282-019-01043-5",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.7535407",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.7526131",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1021080",
"issn": [
"1340-6868",
"1880-4233"
],
"name": "Breast Cancer",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "27"
}
],
"keywords": [
"triple-negative breast cancer",
"immune checkpoint inhibitors",
"breast cancer",
"non-small cell lung cancer",
"microsatellite instability",
"nuclear grade 3",
"PD-L1 expression",
"tumor-infiltrating lymphocytes",
"high-frequency microsatellite instability",
"cell lung cancer",
"breast cancer patients",
"cell death 1",
"renal cell cancer",
"high Ki-67",
"comprehensive genomic profiling",
"presence of MSI",
"Japanese female patient",
"mismatch repair deficiency",
"MSI-H tumors",
"frequency of MSI",
"low-frequency MSI",
"normal tissue controls",
"ICI therapy",
"MONO-27",
"checkpoint inhibitors",
"death-1",
"cell cancer",
"urothelial cancer",
"female patients",
"metastatic tumors",
"lung cancer",
"cancer patients",
"malignant melanoma",
"clinical trials",
"treatment strategies",
"NR-21",
"grade 3",
"Ki-67",
"NR-24",
"promising treatment",
"BAT-25",
"BAT-26",
"cancer",
"genomic profiling",
"tumors",
"repair deficiency",
"tissue controls",
"potential target",
"patients",
"biomarkers",
"MSI",
"CD8",
"lymphocytes",
"BackgroundIt",
"therapy",
"melanoma",
"MethodsIn",
"ConclusionsAlthough",
"trials",
"treatment",
"inhibitors",
"markers",
"deficiency",
"expression",
"mutations",
"target",
"control",
"study",
"profiling",
"presence",
"frequency",
"addition",
"strategies",
"instability",
"method",
"version 1.2",
"microsatellite markers",
"results",
"innovative method",
"conventional methods"
],
"name": "Microsatellite instability in Japanese female patients with triple-negative breast cancer",
"pagination": "490-498",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1123831481"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12282-019-01043-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"31907878"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12282-019-01043-5",
"https://app.dimensions.ai/details/publication/pub.1123831481"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:23",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_873.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12282-019-01043-5"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12282-019-01043-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12282-019-01043-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12282-019-01043-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12282-019-01043-5'
This table displays all metadata directly associated to this object as RDF triples.
336 TRIPLES
22 PREDICATES
130 URIs
114 LITERALS
23 BLANK NODES